Flokayson
2021-08-02
Latest
Moderna, Pfizer Hike Vaccine Prices By Up To 25%<blockquote>Moderna和辉瑞将疫苗价格提高高达25%</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":804029295,"tweetId":"804029295","gmtCreate":1627912929417,"gmtModify":1633755343042,"author":{"id":3584436329511358,"idStr":"3584436329511358","authorId":3584436329511358,"authorIdStr":"3584436329511358","name":"Flokayson","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Latest</p></body></html>","htmlText":"<html><head></head><body><p>Latest</p></body></html>","text":"Latest","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/804029295","repostId":1172231827,"repostType":4,"repost":{"id":"1172231827","kind":"news","pubTimestamp":1627910581,"share":"https://www.laohu8.com/m/news/1172231827?lang=zh_CN&edition=full","pubTime":"2021-08-02 21:23","market":"us","language":"en","title":"Moderna, Pfizer Hike Vaccine Prices By Up To 25%<blockquote>Moderna和辉瑞将疫苗价格提高高达25%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1172231827","media":"zerohedge","summary":"Pfizer and Moderna, Inc. have both made clear that they see their COVID vaccination businesses as lo","content":"<p><a href=\"https://laohu8.com/S/PFE\">Pfizer</a> and <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> have both made clear that they see their COVID vaccination businesses as long-term profit drivers, not the public service that enabled them to receive billions of dollars in public money to effectively subsidize their development. And now that jabs from <a href=\"https://laohu8.com/S/CAAS\">China</a> and Russia are facing newfound skepticism across Europe and the emerging world, Big Pharma is showing its true colors, and demanding a massive premium from all buyers of its jabs as Pfizer rolls out its first 'booster jabs'.</p><p><blockquote><a href=\"https://laohu8.com/S/PFE\">辉瑞</a>和<a href=\"https://laohu8.com/S/MRNA\">莫德纳公司。</a>两人都明确表示，他们将新冠疫苗接种业务视为长期利润驱动力，而不是使他们能够获得数十亿美元公共资金来有效补贴其发展的公共服务。现在刺拳来自<a href=\"https://laohu8.com/S/CAAS\">中国</a>俄罗斯正面临着整个欧洲和新兴世界新发现的怀疑，大型制药公司正在展示其真面目，并要求其疫苗的所有买家支付巨额溢价，因为辉瑞推出了第一批“加强疫苗”。</blockquote></p><p> It's interesting that they're raising prices, considering thatthe Pfizer jabhasn't exactlyheld up to the original promise of its efficacy.</p><p><blockquote>有趣的是，考虑到辉瑞疫苗并没有完全兑现其最初的功效承诺，他们正在提高价格。</blockquote></p><p> Despite their original promises not to profit off the vaccines until the pandemic had ended, both companies are now seizing the opportunity to hike prices charged to governments like those in the EU.</p><p><blockquote>尽管两家公司最初承诺在疫情结束之前不会从疫苗中获利，但现在都在抓住机会提高向欧盟等政府收取的价格。</blockquote></p><p> According to the latest EU supply contracts seen by the FT, Pfizer raised the price of its COVID vaccine by more than 25% and Moderna raised its price by more than 10%. Both companies are expected to generate tens of billions of dollars in revenue this year as they sign new deals with countries anxious to secure supplies for potential booster shots.</p><p><blockquote>根据英国《金融时报》看到的最新欧盟供应合同，辉瑞将其COVID疫苗的价格提高了25%以上，Moderna将其价格提高了10%以上。随着两家公司与急于确保潜在加强注射供应的国家签署新协议，预计今年将创造数百亿美元的收入。</blockquote></p><p> Perthe FT,the companies are raising prices now that Phase 3 trial data has showed that their mRNA jabs are more effective than the AstraZeneca and JNJ jabs. But let's not forget another important factor: that both the AstraZeneca and JNJ jabs have been linked to rare yet sometimes fatal blood clots that have made millions of people wary of taking the jabs. In Australia, for example, the AstraZeneca jab is much more available than the Pfizer jabs...but most patients would prefer to wait, despite the intense lockdowns imposed on the population.</p><p><blockquote>据英国《金融时报》报道，由于3期试验数据显示他们的mRNA疫苗比阿斯利康和强生疫苗更有效，这些公司正在提高价格。但我们不要忘记另一个重要因素：阿斯利康和强生疫苗都与罕见但有时致命的血栓有关，这使得数百万人对注射疫苗持谨慎态度。例如，在澳大利亚，阿斯利康疫苗比辉瑞疫苗更容易获得……但大多数患者宁愿等待，尽管对人群实施了严格的封锁。</blockquote></p><p> The new price for a Pfizer shot was €19.50 ($23) vs. €15.50 ($18) previously, according to the contracts seen by the FT.</p><p><blockquote>根据英国《金融时报》看到的合同，辉瑞疫苗的新价格为19.50欧元（23美元），而此前为15.50欧元（18美元）。</blockquote></p><p> The insider who leaked the data to the FT said the pharmaceutical companies argued they deserved more money because their jabs offered increased \"value\" vs. competing vaccines.</p><p><blockquote>向英国《金融时报》泄露数据的内部人士表示，制药公司认为他们应该得到更多的钱，因为与竞争疫苗相比，他们的疫苗提供了更高的“价值”。</blockquote></p><p> In reality, Big Pharma is just trying to do right by its shareholders as sales are expected to boom.</p><p><blockquote>事实上，大型制药公司只是试图为股东做正确的事情，因为销售预计会蓬勃发展。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/cb20962b05dd2a1a50089742b71bd99c\" tg-width=\"1280\" tg-height=\"889\" referrerpolicy=\"no-referrer\">As the FT points out, the EU supply deal was struck at a difficult time for the EU. The AstraZeneca jab that public health leaders had hoped would be the workhorse of the global rollout had been damaged by scandal. The big pharma firms effectively had their government customers over a barrel. What's more, EU members were grousing about \"unfair\" distribution of shots that left some countries short on jabs.</p><p><blockquote>正如英国《金融时报》指出的那样，欧盟供应协议是在欧盟困难时期达成的。公共卫生领导人曾希望阿斯利康疫苗成为全球推广的主力，但该疫苗因丑闻而受损。大型制药公司实际上控制了他们的政府客户。此外，欧盟成员国抱怨疫苗分配“不公平”，导致一些国家缺乏疫苗。</blockquote></p><p> <a href=\"https://laohu8.com/S/JE\">Just</a> last week, Pfizer last week raised its guidance for annual vaccine revenue by nearly <a href=\"https://laohu8.com/S/AONE.U\">one</a>-third to $33.5 billion, after sales of the shot helped almost double sales in the second quarter.</p><p><blockquote><a href=\"https://laohu8.com/S/JE\">刚刚</a>上周，辉瑞上周将年度疫苗收入指引上调了近<a href=\"https://laohu8.com/S/AONE.U\">一</a>-第三，达到335亿美元，此前该镜头的销售额在第二季度几乎翻了一番。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/5b4fabb71aac47f3f630bde49b1c1c8b\" tg-width=\"1280\" tg-height=\"937\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Fortunately for shareholders, sales to high-income countries likely won't be slowing any time soon as governments prepare to start inoculating minors, and booster shots are being doled out already in Israel.</p><p><blockquote>对股东来说幸运的是，随着政府准备开始为未成年人接种疫苗，对高收入国家的销售可能不会很快放缓，而且以色列已经在发放加强疫苗。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, Pfizer Hike Vaccine Prices By Up To 25%<blockquote>Moderna和辉瑞将疫苗价格提高高达25%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, Pfizer Hike Vaccine Prices By Up To 25%<blockquote>Moderna和辉瑞将疫苗价格提高高达25%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">zerohedge</strong><span class=\"h-time small\">2021-08-02 21:23</span>\n</p>\n</h4>\n</header>\n<article>\n<p><a href=\"https://laohu8.com/S/PFE\">Pfizer</a> and <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> have both made clear that they see their COVID vaccination businesses as long-term profit drivers, not the public service that enabled them to receive billions of dollars in public money to effectively subsidize their development. And now that jabs from <a href=\"https://laohu8.com/S/CAAS\">China</a> and Russia are facing newfound skepticism across Europe and the emerging world, Big Pharma is showing its true colors, and demanding a massive premium from all buyers of its jabs as Pfizer rolls out its first 'booster jabs'.</p><p><blockquote><a href=\"https://laohu8.com/S/PFE\">辉瑞</a>和<a href=\"https://laohu8.com/S/MRNA\">莫德纳公司。</a>两人都明确表示，他们将新冠疫苗接种业务视为长期利润驱动力，而不是使他们能够获得数十亿美元公共资金来有效补贴其发展的公共服务。现在刺拳来自<a href=\"https://laohu8.com/S/CAAS\">中国</a>俄罗斯正面临着整个欧洲和新兴世界新发现的怀疑，大型制药公司正在展示其真面目，并要求其疫苗的所有买家支付巨额溢价，因为辉瑞推出了第一批“加强疫苗”。</blockquote></p><p> It's interesting that they're raising prices, considering thatthe Pfizer jabhasn't exactlyheld up to the original promise of its efficacy.</p><p><blockquote>有趣的是，考虑到辉瑞疫苗并没有完全兑现其最初的功效承诺，他们正在提高价格。</blockquote></p><p> Despite their original promises not to profit off the vaccines until the pandemic had ended, both companies are now seizing the opportunity to hike prices charged to governments like those in the EU.</p><p><blockquote>尽管两家公司最初承诺在疫情结束之前不会从疫苗中获利，但现在都在抓住机会提高向欧盟等政府收取的价格。</blockquote></p><p> According to the latest EU supply contracts seen by the FT, Pfizer raised the price of its COVID vaccine by more than 25% and Moderna raised its price by more than 10%. Both companies are expected to generate tens of billions of dollars in revenue this year as they sign new deals with countries anxious to secure supplies for potential booster shots.</p><p><blockquote>根据英国《金融时报》看到的最新欧盟供应合同，辉瑞将其COVID疫苗的价格提高了25%以上，Moderna将其价格提高了10%以上。随着两家公司与急于确保潜在加强注射供应的国家签署新协议，预计今年将创造数百亿美元的收入。</blockquote></p><p> Perthe FT,the companies are raising prices now that Phase 3 trial data has showed that their mRNA jabs are more effective than the AstraZeneca and JNJ jabs. But let's not forget another important factor: that both the AstraZeneca and JNJ jabs have been linked to rare yet sometimes fatal blood clots that have made millions of people wary of taking the jabs. In Australia, for example, the AstraZeneca jab is much more available than the Pfizer jabs...but most patients would prefer to wait, despite the intense lockdowns imposed on the population.</p><p><blockquote>据英国《金融时报》报道，由于3期试验数据显示他们的mRNA疫苗比阿斯利康和强生疫苗更有效，这些公司正在提高价格。但我们不要忘记另一个重要因素：阿斯利康和强生疫苗都与罕见但有时致命的血栓有关，这使得数百万人对注射疫苗持谨慎态度。例如，在澳大利亚，阿斯利康疫苗比辉瑞疫苗更容易获得……但大多数患者宁愿等待，尽管对人群实施了严格的封锁。</blockquote></p><p> The new price for a Pfizer shot was €19.50 ($23) vs. €15.50 ($18) previously, according to the contracts seen by the FT.</p><p><blockquote>根据英国《金融时报》看到的合同，辉瑞疫苗的新价格为19.50欧元（23美元），而此前为15.50欧元（18美元）。</blockquote></p><p> The insider who leaked the data to the FT said the pharmaceutical companies argued they deserved more money because their jabs offered increased \"value\" vs. competing vaccines.</p><p><blockquote>向英国《金融时报》泄露数据的内部人士表示，制药公司认为他们应该得到更多的钱，因为与竞争疫苗相比，他们的疫苗提供了更高的“价值”。</blockquote></p><p> In reality, Big Pharma is just trying to do right by its shareholders as sales are expected to boom.</p><p><blockquote>事实上，大型制药公司只是试图为股东做正确的事情，因为销售预计会蓬勃发展。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/cb20962b05dd2a1a50089742b71bd99c\" tg-width=\"1280\" tg-height=\"889\" referrerpolicy=\"no-referrer\">As the FT points out, the EU supply deal was struck at a difficult time for the EU. The AstraZeneca jab that public health leaders had hoped would be the workhorse of the global rollout had been damaged by scandal. The big pharma firms effectively had their government customers over a barrel. What's more, EU members were grousing about \"unfair\" distribution of shots that left some countries short on jabs.</p><p><blockquote>正如英国《金融时报》指出的那样，欧盟供应协议是在欧盟困难时期达成的。公共卫生领导人曾希望阿斯利康疫苗成为全球推广的主力，但该疫苗因丑闻而受损。大型制药公司实际上控制了他们的政府客户。此外，欧盟成员国抱怨疫苗分配“不公平”，导致一些国家缺乏疫苗。</blockquote></p><p> <a href=\"https://laohu8.com/S/JE\">Just</a> last week, Pfizer last week raised its guidance for annual vaccine revenue by nearly <a href=\"https://laohu8.com/S/AONE.U\">one</a>-third to $33.5 billion, after sales of the shot helped almost double sales in the second quarter.</p><p><blockquote><a href=\"https://laohu8.com/S/JE\">刚刚</a>上周，辉瑞上周将年度疫苗收入指引上调了近<a href=\"https://laohu8.com/S/AONE.U\">一</a>-第三，达到335亿美元，此前该镜头的销售额在第二季度几乎翻了一番。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/5b4fabb71aac47f3f630bde49b1c1c8b\" tg-width=\"1280\" tg-height=\"937\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Fortunately for shareholders, sales to high-income countries likely won't be slowing any time soon as governments prepare to start inoculating minors, and booster shots are being doled out already in Israel.</p><p><blockquote>对股东来说幸运的是，随着政府准备开始为未成年人接种疫苗，对高收入国家的销售可能不会很快放缓，而且以色列已经在发放加强疫苗。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.zerohedge.com/covid-19/moderna-pfizer-hike-vaccine-prices-25?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29\">zerohedge</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.zerohedge.com/covid-19/moderna-pfizer-hike-vaccine-prices-25?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172231827","content_text":"Pfizer and Moderna, Inc. have both made clear that they see their COVID vaccination businesses as long-term profit drivers, not the public service that enabled them to receive billions of dollars in public money to effectively subsidize their development. And now that jabs from China and Russia are facing newfound skepticism across Europe and the emerging world, Big Pharma is showing its true colors, and demanding a massive premium from all buyers of its jabs as Pfizer rolls out its first 'booster jabs'.\nIt's interesting that they're raising prices, considering thatthe Pfizer jabhasn't exactlyheld up to the original promise of its efficacy.\nDespite their original promises not to profit off the vaccines until the pandemic had ended, both companies are now seizing the opportunity to hike prices charged to governments like those in the EU.\nAccording to the latest EU supply contracts seen by the FT, Pfizer raised the price of its COVID vaccine by more than 25% and Moderna raised its price by more than 10%. Both companies are expected to generate tens of billions of dollars in revenue this year as they sign new deals with countries anxious to secure supplies for potential booster shots.\nPerthe FT,the companies are raising prices now that Phase 3 trial data has showed that their mRNA jabs are more effective than the AstraZeneca and JNJ jabs. But let's not forget another important factor: that both the AstraZeneca and JNJ jabs have been linked to rare yet sometimes fatal blood clots that have made millions of people wary of taking the jabs. In Australia, for example, the AstraZeneca jab is much more available than the Pfizer jabs...but most patients would prefer to wait, despite the intense lockdowns imposed on the population.\nThe new price for a Pfizer shot was €19.50 ($23) vs. €15.50 ($18) previously, according to the contracts seen by the FT.\nThe insider who leaked the data to the FT said the pharmaceutical companies argued they deserved more money because their jabs offered increased \"value\" vs. competing vaccines.\nIn reality, Big Pharma is just trying to do right by its shareholders as sales are expected to boom.\nAs the FT points out, the EU supply deal was struck at a difficult time for the EU. The AstraZeneca jab that public health leaders had hoped would be the workhorse of the global rollout had been damaged by scandal. The big pharma firms effectively had their government customers over a barrel. What's more, EU members were grousing about \"unfair\" distribution of shots that left some countries short on jabs.\nJust last week, Pfizer last week raised its guidance for annual vaccine revenue by nearly one-third to $33.5 billion, after sales of the shot helped almost double sales in the second quarter.\n\nFortunately for shareholders, sales to high-income countries likely won't be slowing any time soon as governments prepare to start inoculating minors, and booster shots are being doled out already in Israel.","news_type":1,"symbols_score_info":{"PFE":0.9,"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":399,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":6,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/804029295"}
精彩评论